<DOC>
	<DOCNO>NCT00212017</DOCNO>
	<brief_summary>The purpose study evaluate whether alpha-glucosidase inhibitor , drug suppression postprandial hyperglycemia , could reduce recurrence myocardial infarction patient impair glucose tolerance ( IGT ) old myocardial infarction .</brief_summary>
	<brief_title>Assessment Alpha-Glucosidase Inhibitor Block Cardiac Events Patients With Myocardial Infarction IGT ( ABC Study )</brief_title>
	<detailed_description>Type 2 diabetes mellitus well-established risk factor coronary heart disease atherosclerotic change coronary artery develop subclinically state impair glucose tolerance ( IGT ) . Recently postprandial hyperglycemia feature impair glucose tolerance recognize significant risk factor coronary heart disease . So designed prospective randomize multi-center trial name Assessment α-glucosidase-inhibitor Block Cardiac Events Patients With Myocardial Infarction IGT ( ABC study ) evaluate whether α-Glucosidase Inhibitor , drug suppression postprandial hyperglycemia , could reduce recurrence myocardial infarction patient IGT old myocardial infarction . 100 hospital participate ABC study . Patients IGT history prior myocardial infarction randomly allocate receive α-Glucosidase Inhibitor ( voglibose ) standard diet exercise treatment . The number patient recruit 3000 study continue least 2 year . The primary end-points : 1. cardiovascular mortality 2. hospitalization cardiovascular event . Effects suppression new diabetes development also evaluate . We recognize IGT important therapeutic target decrease recurrence cardiovascular event . The ABC study , large scale multi-center trial Japan , provide u new evidence treat IGT patient prior myocardial infarction .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Glycoside Hydrolase Inhibitors</mesh_term>
	<mesh_term>Voglibose</mesh_term>
	<criteria>1 . Impaired glucose tolerance 2 . History myocardial infarction 1 . Type I diabetes 2 . History coronary artery bypass graft 3 . Severe liver and/or kidney dysfunction 4 . History allergic response drug 5 . Arteriosclerosis obliterans</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>IGT</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>alpha-glucosidase inhibitor</keyword>
	<keyword>re-infarction prevention</keyword>
</DOC>